- Home
- TIL vs TEAD Comparison
TIL vs TEAD Comparison
Compare TIL & TEAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- TEAD
- Stock Information
- Founded
- TIL 2018
- TEAD 2006
- Country
- TIL United States
- TEAD United States
- Employees
- TIL N/A
- TEAD N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- TEAD
- Sector
- TIL Health Care
- TEAD
- Exchange
- TIL Nasdaq
- TEAD NYSE
- Market Cap
- TIL 230.1M
- TEAD 241.4M
- IPO Year
- TIL 2021
- TEAD N/A
- Fundamental
- Price
- TIL $31.69
- TEAD $2.95
- Analyst Decision
- TIL Buy
- TEAD
- Analyst Count
- TIL 5
- TEAD 0
- Target Price
- TIL $119.00
- TEAD N/A
- AVG Volume (30 Days)
- TIL 263.6K
- TEAD 396.1K
- Earning Date
- TIL 08-12-2025
- TEAD 08-16-2025
- Dividend Yield
- TIL N/A
- TEAD N/A
- EPS Growth
- TIL N/A
- TEAD N/A
- EPS
- TIL N/A
- TEAD N/A
- Revenue
- TIL N/A
- TEAD $959,268,000.00
- Revenue This Year
- TIL N/A
- TEAD $65.64
- Revenue Next Year
- TIL N/A
- TEAD $5.29
- P/E Ratio
- TIL N/A
- TEAD N/A
- Revenue Growth
- TIL N/A
- TEAD 4.15
- 52 Week Low
- TIL $9.85
- TEAD $2.32
- 52 Week High
- TIL $92.00
- TEAD $7.87
- Technical
- Relative Strength Index (RSI)
- TIL 60.55
- TEAD N/A
- Support Level
- TIL $25.58
- TEAD N/A
- Resistance Level
- TIL $32.76
- TEAD N/A
- Average True Range (ATR)
- TIL 2.55
- TEAD 0.00
- MACD
- TIL 0.75
- TEAD 0.00
- Stochastic Oscillator
- TIL 89.55
- TEAD 0.00
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About TEAD TEADS HLDG CO
Teads Holding Co is the omnichannel outcomes platform for the open internet, driving full-funnel results for marketers across premium media. Its Focus on meaningful business outcomes for branding and performance objectives, the combined company ensures value is driven with every media dollar by leveraging predictive AI technology to connect quality media, beautiful brand creative, and context-driven addressability and measurement.